Management of Oropharyngeal Lesions

Initial Diagnostic Workup

The British Journal of Cancer recommends obtaining a tissue biopsy for histological confirmation as the immediate priority, to rule out malignancy which is the most critical diagnosis affecting mortality and morbidity 1, 2
Biopsy for histological confirmation is the standard of care and must be performed first, according to the British Journal of Cancer 1, 2, 3
Documenting the lesion's morphology, measuring its dimensions, and assessing for infiltration of adjacent structures is crucial, as suggested by the British Journal of Cancer 1, 2
A thorough cervical lymph node examination should be performed, documenting presence, sites, dimensions, mobility, and number of nodes, as recommended by the British Journal of Cancer 1, 2, 3

Assessing for alcohol and tobacco use history is essential, as these are common etiologic factors for oropharyngeal malignancy, according to the British Journal of Cancer and the Journal of the National Comprehensive Cancer Network 1, 4

A chest X-ray to detect synchronous bronchial tumors is a standard investigation, as recommended by the British Journal of Cancer 1, 2, 3
Orthopantomography to identify dental defects requiring correction before treatment is also a standard investigation, according to the British Journal of Cancer 1, 2, 3

A CT scan or MRI of head and neck may be performed if deep muscle and/or bone involvement is suspected, as suggested by the British Journal of Cancer 1, 2, 3
PET-CT may be used for stage III-IV disease, according to the Journal of the National Comprehensive Cancer Network 4

For confirmed malignancy, treatment depends on T-stage and location within the oropharynx, with external radiotherapy, radiotherapy plus brachytherapy, or surgery followed by postoperative radiotherapy providing equivalent local control for limited stage disease (T1-T2), as recommended by the British Journal of Cancer 1, 2, 3
For T3 tumors, combination radiotherapy and brachytherapy is superior to radiotherapy alone, according to the British Journal of Cancer 1, 2, 3
For advanced disease, concurrent chemoradiation with cisplatin 100 mg/m² every 3 weeks is the standard approach, as recommended by the Journal of the National Comprehensive Cancer Network 4
Postoperative management may include additional radiotherapy or chemoradiation if surgical margins are narrow or invaded, or if extracapsular spread is present, as suggested by the British Journal of Cancer and the Journal of the National Comprehensive Cancer Network 1, 2, 4, 3